A major drug industry trade group and the federal government have asked a federal judge to continue to pause litigation [...] …
Category: Pharma Industry
An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal government’s recent threat to penalize Johnson & Johnson (J&J) for its unapproved 340B rebate model could spark a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district judge ruled that four drugmakers’ 340B contract pharmacy restrictions—as implemented in 2021—do not violate the 340B statute, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency that oversees the 340B program today formally warned Johnson & Johnson (J&J) that it must “cease implementation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The sponsor of new Senate legislation that would codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four diabetes drugmakers are urging a federal appeals court to uphold a lower court’s decision to dismiss 340B antitrust claims [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...] …
